Published in Adv Exp Med Biol on January 01, 1995
Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. J Virol (2001) 1.43
Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol (1998) 1.24
The spike protein of murine coronavirus mouse hepatitis virus strain A59 is not cleaved in primary glial cells and primary hepatocytes. J Virol (1998) 1.12
Brain Invasion by Mouse Hepatitis Virus Depends on Impairment of Tight Junctions and Beta Interferon Production in Brain Microvascular Endothelial Cells. J Virol (2015) 0.77
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology (2011) 4.25
Crystal structure of a small heat-shock protein. Nature (1998) 4.07
Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science (1989) 3.90
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol (1999) 3.03
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci U S A (1997) 2.99
Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion. Virology (1982) 2.94
Structure-based assignment of the biochemical function of a hypothetical protein: a test case of structural genomics. Proc Natl Acad Sci U S A (1998) 2.70
Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology (1984) 2.57
The Madurai Intraocular Lens Study. II: Clinical outcomes. Am J Ophthalmol (1998) 2.46
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology (2008) 2.29
Crystal structure of a fibrillarin homologue from Methanococcus jannaschii, a hyperthermophile, at 1.6 A resolution. EMBO J (2000) 2.20
Morphological features of TMPRSS2-ERG gene fusion prostate cancer. J Pathol (2007) 2.17
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology (2007) 2.17
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology (2008) 2.11
Risk of human immunodeficiency virus in surgeons, anesthesiologists, and medical students. Anesth Analg (1992) 2.03
Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol (2008) 1.99
Topographical mapping of epitopes on the glycoproteins of murine hepatitis virus-4 (strain JHM): correlation with biological activities. Virology (1984) 1.69
Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surg Br (1995) 1.65
Crystal structure of an intracellular protease from Pyrococcus horikoshii at 2-A resolution. Proc Natl Acad Sci U S A (2000) 1.65
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol (1996) 1.64
BeF(3)(-) acts as a phosphate analog in proteins phosphorylated on aspartate: structure of a BeF(3)(-) complex with phosphoserine phosphatase. Proc Natl Acad Sci U S A (2001) 1.62
Mouse hepatitis virus type 4 (JHM strains). induced fatal central nervous system disease. I. genetic control and murine neuron as the susceptible site of disease. J Exp Med (1981) 1.60
Western and dot immunoblotting analysis of viral antigens and antibodies: application to murine hepatitis virus. J Immunol Methods (1984) 1.58
Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol (2002) 1.58
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology (2007) 1.56
Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis. J Am Acad Dermatol (1996) 1.55
Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia. Ann Neurol (1989) 1.55
A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology (1997) 1.54
Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii. Biochemistry (2001) 1.54
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators. Neurology (2000) 1.52
Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry (2010) 1.49
Age-related marrow conversion in the proximal metaphysis of the femur: evaluation with T1-weighted MR imaging. Radiology (1998) 1.47
Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. J Exp Med (1985) 1.46
Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature (1982) 1.46
Terahertz dark-field imaging of biomedical tissue. Opt Express (2001) 1.45
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology (2007) 1.45
Quantifying the extent of osteonecrosis of the femoral head. A new method using MRI. J Bone Joint Surg Br (1995) 1.45
Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas. Neurology (2006) 1.44
Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes. Infect Immun (1997) 1.44
Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis. Arch Neurol (2001) 1.40
An internalized double-J catheter for percutaneous transgastric cystogastrostomy. AJR Am J Roentgenol (1989) 1.40
Selective localization of wild type and mutant mouse hepatitis virus (JHM strain) antigens in CNS tissue by fluorescence, light and electron microscopy. J Neuroimmunol (1981) 1.39
Crystal structure of phosphoserine phosphatase from Methanococcus jannaschii, a hyperthermophile, at 1.8 A resolution. Structure (2001) 1.39
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc Natl Acad Sci U S A (1998) 1.35
Systemic alpha-interferon therapy of multiple sclerosis. Neurology (1984) 1.35
Mechanisms and genetics of resistance to sodium lauryl sulfate in strains of Shigella and Escherichia coli. Infect Immun (1971) 1.30
Fatal cerebral hemorrhage due to autonomic dysreflexia in a tetraplegic patient: case report and review. Paraplegia (1992) 1.27
Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group. Neurology (1994) 1.27
Crystal structures of eukaryotic translation initiation factor 5A from Methanococcus jannaschii at 1.8 A resolution. Proc Natl Acad Sci U S A (1998) 1.26
Crystal structure of archaeal RNase HII: a homologue of human major RNase H. Structure (2000) 1.26
Isolation of gram quantities of EcoRI restriction and modification enzymes from an overproducing strain. J Biol Chem (1984) 1.26
A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology (1984) 1.24
Actual colonoscopy: what are the risks of perforation? Am Surg (2001) 1.20
Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions. J Physiol (2001) 1.20
Bone marrow edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial MR images. Radiology (1999) 1.18
Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8. J Neuroimmunol (1984) 1.18
Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity (1993) 1.18
Purification, some catalytic and molecular properties of phosphoribulokinase from Alcaligenes eutrophus. Biochim Biophys Acta (1981) 1.17
Drug resistance associated with altered DNA topoisomerase II. Adv Enzyme Regul (1993) 1.16
Factors relating to readmission of term and near-term neonates in the first two weeks of life. Early Discharge Survey Group of the Health Professional Advisory Board of the Greater New York Chapter of the March of Dimes. J Perinat Med (1999) 1.15
Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg (1997) 1.15
Assessing disability progression with the Multiple Sclerosis Functional Composite. Mult Scler (2009) 1.15
Retinal pattern dystrophy associated with a 4 bp insertion at codon 140 in the RDS-peripherin gene. Hum Mol Genet (1994) 1.14
Observer agreement in the assessment of narrowband imaging system surface patterns in Barrett's esophagus: a multicenter study. Endoscopy (2011) 1.13
Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS. Neurology (1999) 1.12
Host genetic control of mouse hepatitis virus type 4 (JHM strain) replication. I. Restriction of virus amplification and spread in macrophages from resistant mice. J Gen Virol (1984) 1.12
Isolation and cDNA cloning of Ksp-cadherin, a novel kidney-specific member of the cadherin multigene family. J Biol Chem (1995) 1.12
A common human beta globin splicing mutation modeled in mice. Blood (1998) 1.11
Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology (1995) 1.10
F-actin disruption attenuates agonist-induced [Ca2+], myosin phosphorylation, and force in smooth muscle. Am J Physiol (1997) 1.09
Argon laser treatment for premacular hemorrhage. Retina (1998) 1.08
Characterization of an 18,166 EST dataset for cassava (Manihot esculenta Crantz) enriched for drought-responsive genes. Plant Cell Rep (2007) 1.08
Redesigning a sweet protein: increased stability and renaturability. Protein Eng (1989) 1.08
Letter: Tetracycline therapy for atypical mycobacterial granuloma. Arch Dermatol (1974) 1.07
Molecular cloning and expression of the ilvGEDAY genes from Salmonella typhimurium. J Bacteriol (1981) 1.07
Flushing syndrome due to mahimahi (scombroid fish) poisoning. Arch Dermatol (1979) 1.05
Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy. Eye (Lond) (2006) 1.05
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a. Neurology (2009) 1.05
Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study. J Rheumatol (2000) 1.04
Delayed, relapsing experimental allergic encephalomyelitis in mice. J Immunol (1981) 1.03
Hypoxia-induced regulation of MAPK phosphatase-1 as identified by subtractive suppression hybridization and cDNA microarray analysis. J Biol Chem (2001) 1.03
Zebrafish nma is involved in TGFbeta family signaling. Genesis (2000) 1.03
Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Pathobiology of disease induced by wild type and mutants ts8 and ts15 in BALB/c and SJL/J mice. Am J Pathol (1982) 1.02
Host genetic regulation of acute MHV-4 viral encephalomyelitis and acute experimental autoimmune encephalomyelitis in (BALB/cKe x SJL/J) recombinant-inbred mice. J Neuroimmunol (1985) 1.02
Projections of the globus pallidus and adjacent structures: an autoradiographic study in the monkey. J Comp Neurol (1976) 1.01
Factors affecting virulence of Shigella flexneri: avirulent strain with altered metablism of succinate, fumarate, and malate. Infect Immun (1973) 1.01
Direct measurement of DNA unwinding angle in specific interaction between lac operator and repressor. Cold Spring Harb Symp Quant Biol (1983) 1.01
Abnormal cerebral microstructure in premature neonates with congenital heart disease. AJNR Am J Neuroradiol (2013) 1.01
Macular hole secondary to X-linked retinoschisis. Eye (Lond) (2006) 0.98